According to FibroGen's latest financial reports the company's current EPS (TTM) is -HK$26.30. In 2022 the company made an earnings per share (EPS) of -HK$24.36 a decrease over its 2021 EPS that were of -HK$24.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$26.57 | 9.1% |
2022 | -HK$24.36 | -0% |
2021 | -HK$24.36 | 48.11% |
2020 | -HK$16.45 | 140.91% |
2019 | -HK$6.83 | -14.56% |
2018 | -HK$7.99 | -32.68% |
2017 | -HK$11.87 | 64.52% |
2016 | -HK$7.21 | -34.51% |
2015 | -HK$11.02 | -6.98% |
2014 | -HK$11.84 |